HQL
Tekla Life Sciences Investors
17.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 0.8% | 2.8% | 0.2% | 0.6% | 0.0% | 1.3% | 0.0% | 0.0% | 0.1% | 0.0% | 0.2% | 0.4% | |
| 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | -3.1% | 0.0% | 0.0% | 0.0% | – | |
| 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 3.8% | 3.1% | 3.1% | 0.0% | 3.0% | 0.0% | 0.2% | |
| 0.7% | 0.2% | 0.2% | 0.0% | 0.0% | 1.3% | 0.0% | 0.0% | 0.1% | 1.6% | 0.2% | 0.2% | |
| 5.8% | 0.0% | 8.1% | 0.0% | 2.8% | 5.0% | – | -3.1% | – | – | – | – | |
| 2.9% | 4.1% | 4.1% | 2.3% | 2.3% | 0.2% | 0.2% | 0.2% | 0.2% | 3.7% | 0.3% | 0.4% | |
| 0.8% | 4.1% | 1.2% | 2.3% | 2.3% | – | 0.2% | 0.2% | 0.2% | 3.7% | 0.1% | 0.1% | |
| 0.0% | 2.7% | 0.0% | 2.2% | 0.0% | – | – | – | – | – | – | – | |
| 0.8% | 1.2% | 1.2% | – | 0.0% | – | 0.1% | 0.1% | 0.0% | 1.6% | 0.1% | 0.0% | |
| 97.1% | 95.9% | 95.9% | 97.7% | 97.7% | 99.8% | 99.8% | 99.8% | 99.8% | 96.3% | 99.7% | 99.6% | |
| 12.1% | 2.3% | 2.3% | 6.2% | 6.2% | -0.4% | 6.8% | 6.8% | 9.6% | -7.4% | 15.1% | 19.8% | |
| 5.6% | 0.0% | 6.2% | 0.0% | 6.1% | 6.7% | 6.2% | 6.2% | 6.2% | 7.0% | 5.6% | 5.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.